Ajani JA - Search Results

1

A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.

Blum M, Suzuki A, Ajani JA. Blum M, et al. Among authors: ajani ja. Future Oncol. 2011 Jun;7(6):715-26. doi: 10.2217/fon.11.50. Future Oncol. 2011. PMID: 21675835 Review.

2

Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.

Partyka S, Dumas P, Ajani J. Partyka S, et al. Cancer. 1999 Jun 1;85(11):2336-9. doi: 10.1002/(sici)1097-0142(19990601)85:11<2336::aid-cncr6>3.0.co;2-i. Cancer. 1999. PMID: 10357402 Clinical Trial.

3

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.

Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C. Ajani JA, et al. Cancer. 2002 Feb 1;94(3):641-6. doi: 10.1002/cncr.10279. Cancer. 2002. PMID: 11857295 Free article. Clinical Trial.

4

Adjuvant and preoperative chemotherapy for gastric cancer.

Yao JC, Ajani JA. Yao JC, et al. Among authors: ajani ja. Curr Oncol Rep. 2002 May;4(3):222-8. doi: 10.1007/s11912-002-0019-x. Curr Oncol Rep. 2002. PMID: 11937012 Review.

5

Docetaxel for gastric and esophageal carcinomas.

Ajani JA. Ajani JA. Oncology (Williston Park). 2002 Jun;16(6 Suppl 6):89-96. Oncology (Williston Park). 2002. PMID: 12108902 Free article. Review.

6

Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma.

Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C. Ajani JA, et al. Oncology (Williston Park). 2002 May;16(5 Suppl 5):16-8. Oncology (Williston Park). 2002. PMID: 12109800 Free article. Clinical Trial.

7

Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001.

Hasham-Jiwa N, Kasakura Y, Ajani JA. Hasham-Jiwa N, et al. Among authors: ajani ja. Int J Clin Oncol. 2002 Aug;7(4):219-24. doi: 10.1007/s101470200033. Int J Clin Oncol. 2002. PMID: 12202975 Review.

8

Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.

Hoff PM, Saad ED, Ajani JA, Lassere Y, Wenske C, Medgyesy D, Dwivedy S, Russo M, Pazdur R. Hoff PM, et al. Among authors: ajani ja. Clin Cancer Res. 2003 Jan;9(1):134-42. Clin Cancer Res. 2003. PMID: 12538461 Clinical Trial.

9

Docetaxel in combination for advanced gastric cancer.

Ajani JA. Ajani JA. Gastric Cancer. 2002;5 Suppl 1:31-4. doi: 10.1007/s10120-002-0215-2. Gastric Cancer. 2002. PMID: 12772885 Clinical Trial.

10

Chemoradiation for resectable gastric cancer.

Xiong HQ, Gunderson LL, Yao J, Ajani JA. Xiong HQ, et al. Among authors: ajani ja. Lancet Oncol. 2003 Aug;4(8):498-505. doi: 10.1016/s1470-2045(03)01170-7. Lancet Oncol. 2003. PMID: 12901965 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

797 results

Search Page

Filters